Penn have extensive experience in providing services to companies developing products in key 21st century specialist areas, including:

• Oncology (systemic and topical therapies)
• CNS disorders
• Diabetes and other metabolic disorders
• Orphan drug development and manufacture
• Paediatric medicines
• Biosimilars
• Niche generics

In addition to having an excellent understanding of the formulation development, clinical supplies and manufacturing requirements in these areas, Penn can provide CMC and QP consultancy expertise to help clients expedite the development of their products from clinic to market.